25 results on '"Ljungman, Per"'
Search Results
2. Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
3. Respiratory Syncytial Virus Infection in Recipients of Allogeneic Stem-Cell Transplantation: A Retrospective Study of the Incidence, Clinical Features, and Outcome
4. Antifungal Therapy Strategies in Hematopoietic Stem-Cell Transplant Recipients: Early Treatment Options for Improving Outcomes
5. Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients After Stem Cell Transplantation
6. Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Disorders: Experience in a Single Center
7. Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus
8. Clinical tolerance after allogeneic hematopoietic stem cell transplantation
9. REAL-TIME MONITORING OF CYTOMEGALOVIRUS INFECTIONS AFTER STEM CELL TRANSPLANTATION USING THE TaqMan POLYMERASE CHAIN REACTION ASSAYS1
10. THE ROLE OF HEPATITIS C AND B VIRUS INFECTIONS AS RISK FACTORS FOR SEVERE LIVER COMPLICATIONS FOLLOWING ALLOGENEIC BMT: A PROSPECTIVE STUDY BY THE INFECTIOUS DISEASE WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP1
11. RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1
12. CD13-SPECIFIC AUTOIMMUNITY IN CYTOMEGALOVIRUS-INFECTED IMMUNOCOMPROMISED PATIENTS1
13. CYTOMEGALOVIRUS-INDUCED CD13-SPECIFIC AUTOIMMUNITY-A POSSIBLE CAUSE OF CHRONIC GRAFT-VERSUS-HOST DISEASE1
14. DOES HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE MARROW TRANSPLANTATION INCREASE MORTALITY IN VENO-OCCLUSIVE DISEASE OF THE LIVER?
15. CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES AND PLASMA FROM BONE MARROW TRANSPLANT RECIPIENTS
16. REAL-TIME MONITORING OF CYTOMEGALOVIRUS INFECTIONS AFTER STEM CELL TRANSPLANTATION USING THE TaqMan POLYMERASE CHAIN REACTION ASSAYS1.
17. THE ROLE OF HEPATITIS C AND B VIRUS INFECTIONS AS RISK FACTORS FOR SEVERE LIVER COMPLICATIONS FOLLOWING ALLOGENEIC BMT: A PROSPECTIVE STUDY BY THE INFECTIOUS DISEASE WORKING PARTY OF THE EUROPEAN BLOOD AND MARROW TRANSPLANTATION GROUP1.
18. RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1.
19. CYTOMEGALOVIRUS-INDUCED CD13-SPECIFIC AUTOIMMUNITY-A POSSIBLE CAUSE OF CHRONIC GRAFT-VERSUS-HOST DISEASE1.
20. CD13-SPECIFIC AUTOIMMUNITY IN CYTOMEGALOVIRUS-INFECTED IMMUNOCOMPROMISED PATIENTS1.
21. LYMPHOCYTE RESPONSES AFTER CYTOMEGALOVIRUS INFECTION IN BONE MARROW TRANSPLANT RECIPIENTS—A ONE-YEAR FOLLOW-UP.
22. IgG-SUBCLASS-SPECIFIC CMV REACTIVITY IN BONE MARROW TRANSPLANT RECIPIENTS.
23. LYMPHOCYTE RESPONSES AFTER CYTOMEGALOVIRUS INFECTION IN BONE MARROW TRANSPLANT RECIPIENTS—A ONEYEAR FOLLOWUP
24. IgGSUBCLASSSPECIFIC CMV REACTIVITY IN BONE MARROW TRANSPLANT RECIPIENTS
25. DOES HIGHDOSE INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE MARROW TRANSPLANTATION INCREASE MORTALITY IN VENOOCCLUSIVE DISEASE OF THE LIVER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.